These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. High-dose methylprednisolone in the treatment of bullous pemphigoid. Siegel J; Eaglstein WH Arch Dermatol; 1984 Sep; 120(9):1157-65. PubMed ID: 6383221 [TBL] [Abstract][Full Text] [Related]
24. Prospective study in bullous pemphigoid: association of high serum anti-BP180 IgG levels with increased mortality and reduced Karnofsky score. Holtsche MM; Goletz S; van Beek N; Zillikens D; Benoit S; Harman K; Walton S; English J; Sticherling M; Chapman A; Levell NJ; Groves R; Williams HC; König IR; Schmidt E; Br J Dermatol; 2018 Oct; 179(4):918-924. PubMed ID: 29607480 [TBL] [Abstract][Full Text] [Related]
25. Low-dose methotrexate treatment in elderly patients with bullous pemphigoid. Paul MA; Jorizzo JL; Fleischer AB; White WL J Am Acad Dermatol; 1994 Oct; 31(4):620-5. PubMed ID: 8089289 [TBL] [Abstract][Full Text] [Related]
26. The value of the pragmatic-explanatory continuum indicator summary wheel in an ongoing study: the bullous pemphigoid steroids and tetracyclines study. Bratton DJ; Nunn AJ; Wojnarowska F; Kirtschig G; Sandell A; Williams HC Trials; 2012 Apr; 13():50. PubMed ID: 22540678 [TBL] [Abstract][Full Text] [Related]
27. A bullous pemphigoid-like skin eruption after a chemical burn. Chen DM; Fairley JA J Am Acad Dermatol; 1998 Feb; 38(2 Pt 2):337-40. PubMed ID: 9486711 [TBL] [Abstract][Full Text] [Related]
28. Long-term treatment outcomes and safety of dupilumab as a therapy for bullous pemphigoid: A multicenter retrospective review. Learned C; Cohen SR; Cunningham K; Alsukait S; Santiago S; Lu J; Rothe M; Nichols A; Rosmarin D J Am Acad Dermatol; 2023 Aug; 89(2):378-382. PubMed ID: 37115111 [No Abstract] [Full Text] [Related]
29. A case of aggressive bullous pemphigoid associated with the defective functional variant of Fc gamma receptor IIb: implications for pathogenesis? Guilabert A; Lozano F; Iranzo P; Suárez-Casasús B; Martinez-De Pablo I; Julià M; Mascaró JM J Am Acad Dermatol; 2011 Nov; 65(5):1062-3. PubMed ID: 22000875 [No Abstract] [Full Text] [Related]
35. Treatment of bullous pemphigoid with low-dose oral cyclophosphamide: a case series of 20 patients. Gual A; Iranzo P; Mascaró JM J Eur Acad Dermatol Venereol; 2014 Jun; 28(6):814-8. PubMed ID: 23581830 [TBL] [Abstract][Full Text] [Related]
36. Photodynamic therapy effective for the treatment of actinic keratosis and basal cell carcinoma in bullous pemphigoid patients. Canavan TN; de la Feld SF; Huang C; Sami N Photodiagnosis Photodyn Ther; 2017 Jun; 18():257-259. PubMed ID: 28373119 [TBL] [Abstract][Full Text] [Related]
37. Bullous pemphigoid following therapy with an oral beta-blocker. Perry A; Sparling JD; Pennington M J Drugs Dermatol; 2005; 4(6):746-8. PubMed ID: 16302561 [TBL] [Abstract][Full Text] [Related]
38. Treatment of bullous pemphigoid and pemphigus. The French experience, 2009 update. Roujeau JC; Ingen-Housz-Oro S; Leroux C; Joly P G Ital Dermatol Venereol; 2009 Aug; 144(4):333-8. PubMed ID: 19755939 [TBL] [Abstract][Full Text] [Related]